Which agent is used to treat severe bleeding in patients with deep venous thrombosis (DVT) taking non–vitamin K antagonist oral anticoagulants (NOACs)?

Updated: Jun 06, 2019
  • Author: Kaushal (Kevin) Patel, MD; Chief Editor: Barry E Brenner, MD, PhD, FACEP  more...
  • Print
Answer

Currently, PCCs can be used to address severe bleeding in patients taking NOACs when administered in high enough dosages. Some guidelines suggest an initial dose of 25 to 50 U/kg of PCCs in life-threatening emergencies, to be repeated if necessary.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!